A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis

Clinical trial NCT01680159 · COMPLETED

Trial details

NCT number: NCT01680159
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis Psoriatic Arthritis Pustular Psoriasis (Excluding a Localized)Psoriatic Erythroderma

Start date: 2012-07-01
Primary completion: 2015-03-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.